BiotechTubeBiotechTube
Home/eXoZymes/Michael Heltzen
MH

Michael Heltzen

Chief Executive Officer (CEO)

eXoZymes

Therapeutic Areas

Metabolic DisordersWellness/NutraceuticalsCannabinoid Therapeutics

eXoZymes Pipeline

DrugIndicationPhase
NCT (Over-the-Counter)Metabolic Wellness / Cellular Energy EfficiencyPre-commercial
NCT (Pharma)Multiple Metabolic DiseasesDiscovery/Pre-clinical
Non-intoxicating CannabinoidsTherapeutic & Commercial ApplicationsDiscovery
SantaleneHigh-Value Fragrance IngredientProcess Development

Leadership Team at eXoZymes

DP
Damien Perriman
Chief Commercial Officer (CCO)
View full eXoZymes profile